Ann Wall

Ann Wall has worked in the healthcare industry since 1998. Ann began their career at TAP Pharmaceuticals as a Sales Representative, where they were awarded the 'Excalibur' Winner in 2000 and 2002, and the 'Team Player Award' in 2000, 2001, and 2002. In 2003, Ann moved to Genentech as a Sales Representative, where they were the 2007 Sales Excellence Award Winner and 2006 Diligence Award Winner. In 2011, Ann joined NeoGenomics Laboratories as a Melanoma Product Specialist, where they collaborated with Stanford University to publish and develop a clinical study validating the efficacy of the Melanoma FISH assay. In 2012, Ann became the Chief Marketing Officer and Sales Representative at Skin Diagnostics Group, PC, where they sold dermatopathology lab services to dermatologists in Louisiana and Mississippi. In 2013, Ann became a Sales Representative at AbbVie, where they sold Humira to Dermatologists. In 2014, Ann returned to Revision Skincare as an Executive Sales Representative, where they were awarded the 'Rookie of the Year' award in 2014, 'Rising Star Award' in 2015 and 2018, and was a member of the 'Presidents Club' from 2015 to 2019. In 2020, Ann began their current role as a Global Business Consultant for Revision Skincare, where they manage global distribution partners across multiple regions for the company.

Ann Wall obtained a Bachelor's degree from The University of Alabama, with a double degree in Business and Education.